In September, the European Medicines Agency's committee recommended against renewing the conditional marketing authorisation for Blenrep, a setback to the key oncology unit GSK has been looking to strengthen. GSK said last month that Blenrep, which was the second-largest contributor to GSK's oncology business in 2022, had reached a key goal in a separate late-stage trial.
15 San Antonio ISD schools recommended for closure under final district proposal tpr.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tpr.org Daily Mail and Mail on Sunday newspapers.